ornithine and Astrocytoma, Grade IV

ornithine has been researched along with Astrocytoma, Grade IV in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chatterton, NP; Inal, JM; Kosgodage, US; Kraev, I; Lange, S; MacLatchy, A; Nicholas, AP; Uysal-Onganer, P	1
Bouziotis, P; Fragogeorgi, EA; Kagadis, GC; Karnabatidis, D; Loudos, G; Palamaris, L; Paravatou-Petsotas, M; Psimadas, D; Tsiapa, I; Varvarigou, AD; Xanthopoulos, S	1
Levin, VA	1

Reviews

1 review(s) available for ornithine and Astrocytoma, Grade IV

Article	Year
Chemotherapy of primary brain tumors. Neurologic clinics, 1985, Volume: 3, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Eflornithine; Ependymoma; Fluorouracil; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methotrexate; Mitoguazone; Mitolactol; Neoplasm Recurrence, Local; Ornithine; Prednisone; Risk; Thioguanine; Vincristine	1985

Article

Year

Chemotherapy of primary brain tumors.

Neurologic clinics, 1985, Volume: 3, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Eflornithine; Ependymoma; Fluorouracil; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methotrexate; Mitoguazone; Mitolactol; Neoplasm Recurrence, Local; Ornithine; Prednisone; Risk; Thioguanine; Vincristine

1985

Other Studies

2 other study(ies) available for ornithine and Astrocytoma, Grade IV

Article	Year
Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme. International journal of molecular sciences, 2018, Dec-28, Volume: 20, Issue:1 Topics: Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Survival; Chromatography, Liquid; Extracellular Vesicles; Glioblastoma; Histones; Humans; MicroRNAs; Ornithine; Prohibitins; Protein Processing, Post-Translational; Protein-Arginine Deiminases; Proteome; Proteomics; Tandem Mass Spectrometry	2018
Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo. Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:10 Topics: Animals; Cell Line, Tumor; Glioblastoma; Humans; Integrin alphaVbeta3; Isotope Labeling; Mice; Mice, SCID; Neovascularization, Pathologic; Oligopeptides; Ornithine; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Tissue Distribution	2014

Article

Year

Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.

International journal of molecular sciences, 2018, Dec-28, Volume: 20, Issue:1

Topics: Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Survival; Chromatography, Liquid; Extracellular Vesicles; Glioblastoma; Histones; Humans; MicroRNAs; Ornithine; Prohibitins; Protein Processing, Post-Translational; Protein-Arginine Deiminases; Proteome; Proteomics; Tandem Mass Spectrometry

2018

Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.

Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:10

Topics: Animals; Cell Line, Tumor; Glioblastoma; Humans; Integrin alphaVbeta3; Isotope Labeling; Mice; Mice, SCID; Neovascularization, Pathologic; Oligopeptides; Ornithine; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Tissue Distribution

2014